Company Profile | April 29, 2013

SynteractHCR - Full-service CRO

 

In 2013, San Diego-based Synteract acquired Munich-based Harrison Clinical Research – and expanded our services and strength to the Power of Two – two excellent CROs that, together as one, deliver international, full-service clinical trial services. Now operating under our new name, SynteractHCR is a dedicated contract research organization with a successful track record of more than two decades supporting pharmaceutical, biotechnology and medical device companies in all phases of clinical development, across multiple therapeutic areas. We work closely with you to customize programs that will deliver timely, high quality data to help you get to decision points faster, taking time and cost out of drug development.


Shared Work – Shared Vision

This is the way we do business, a promised standard that includes ongoing support from a specialized team dedicated to meeting or exceeding your expectations. With our “Shared Work –Shared Vision” philosophy, SynteractHCR provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data. We have been a trusted clinical trial outsourcing partner to clients for many years, and are proud to have supported 68 product approvals since 1987. SynteractHCR manages international clinical trials and offers expertise across multiple therapeutic areas including a notable depth in oncology, cardiovascular, CNS, ophthalmology, respiratory, and nutritional medicine.